Constant detection of cyclooxygenase 2 in terminal stages of myeloid maturation

Acta Haematologica

Volumn 117, Issue 1, 2006, Pages 48-50

  Tripodo, Claudio ^a   Florena, Ada Maria ^a   Porcasi, Rossana ^a   Ingrao, Sabrina ^a   Guarnotta, Carla ^a   Franco, Vito ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BONE MARROW BIOPSY; CANCER STAGING; CELL DEATH; CELL DIFFERENTIATION; CELL GROWTH; CELL STRAIN K 562; CHRONIC MYELOID LEUKEMIA; ENZYME ASSAY; HUMAN; IMMUNOHISTOCHEMISTRY; LEUKEMIA CELL LINE; MEGAKARYOCYTE; MYELODYSPLASTIC SYNDROME; MYELOID METAPLASIA; MYELOPROLIFERATIVE DISORDER; POLYCYTHEMIA VERA; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTHEMIA;

APOPTOSIS; BONE MARROW; BONE MARROW CELLS; CELL DIFFERENTIATION; CYCLOOXYGENASE 2; ERYTHROID PROGENITOR CELLS; HEMATOPOIESIS; HUMANS; MEGAKARYOCYTES; MEMBRANE PROTEINS; MYELODYSPLASTIC SYNDROMES; MYELOID CELLS; MYELOPROLIFERATIVE DISORDERS; NEUTROPHILS; REFERENCE VALUES;

EID: 33845741132     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000096788     Document Type: Article

References (9)

1. Ladetto M, Vallet S, Trojan A, Dell'Aquila M, Monitillo L, Rosato R, Santo L, Drandi D, Bertola A, Falco P, Cavallo F, Ricca I, De Marco F, Mantoan B, Bode-Lesniewska B, Pagliano G, Francese R, Rocci A, Astolfi M, Compagno M, Mariani S, Godio L, Marino L, Ruggeri M, Omede P, Palumbo A, Boccadoro M: Cyclooxygenase-2 (COX-2) is frequently expressed in multiple myeloma and is an independent predictor of poor outcome. Blood 2005;105:4784-4791.
2. Secchiero P, Barbarotto E, Gonelli A, Tiribelli M, Zerbinati C, Celeghini C, Agostinelli C, Pileri SA, Zauli G: Potential pathogenetic implications of cyclooxygenase-2 overexpression in B chronic lymphoid leukemia cells. Am J Pathol 2005;167:1599-1607.
3. Rocca B, Secchiero P, Celeghini C, Ranelletti FO, Ciabattoni G, Maggiano N, Habib A, Ricerca BM, Barbarotto E, Patrono C, Zauli G: Modulation of the expression and activity of cyclooxygenases in normal and accelerated erythropoiesis. Exp Hematol 2004;32:925-934.
4. Zetterberg E, Lundberg LG, Palmblad J: Expression of cox-2, tie-2 and glycodelin by megakaryocytes in patients with chronic myeloid leukaemia and polycythaemia vera. Br J Haematol 2003;121:497-499.
5. Tanaka N, Sato T, Fujita H, Morita I: Constitutive expression and involvement of cyclooxygenase-2 in human megakaryocytopoiesis. Arterioscler Thromb Vasc Biol 2004;24:607-612.
6. Maloney CG, Kutchera WA, Albertine KH, McIntyre TM, Prescott SM, Zimmerman GA: Inflammatory agonists induce cyclooxygenase type 2 expression by human neutrophils. J Immunol 1998;160:1402-1410.
7. Pellagatti A, Esoof N, Watkins F, Langford CF, Vetrie D, Campbell LJ, Fidler C, Cavenagh JD, Eagleton H, Gordon P, Woodcock B, Pushkaran B, Kwan M, Wainscoat JS, Boultwood J: Gene expression profiling in the myelodysplastic syndromes using cDNA microarray technology. Br J Haematol 2004;125:576-583.
8. Subhashini J, Mahipal SV, Reddanna P: Antiproliferative and apoptotic effects of celecoxib on human chronic myeloid leukemia in vitro. Cancer Lett 2005;224:31-43.
9. Zhang GS, Liu DS, Dai CW, Li RJ: Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib. Am J Hematol 2006;81:242-255.